What is DeciBio?
DeciBio operates at the intersection of precision medicine, strategy consulting, and data analytics. The company provides critical market intelligence and consulting partnerships to a diverse clientele, including those in clinical diagnostics, financial services, pharmaceuticals, biotechnology, and research tools. Their comprehensive service offerings encompass in-depth market research, competitive analysis, strategic advisory, and advanced data analytics, all designed to accelerate innovation within the precision medicine ecosystem. DeciBio is committed to navigating market developments and supporting clients throughout their journey from early-stage research to successful commercialization.
How much funding has DeciBio raised?
DeciBio has raised a total of $850K across 2 funding rounds:
Debt
$350K
Debt
$500K
Debt (2020): $350K with participation from PPP
Debt (2024): $500K, investors not publicly disclosed
Key Investors in DeciBio
PPP
Public-Private Partnership
What's next for DeciBio?
The substantial enterprise-level funding, coupled with the recent strategic investment, positions DeciBio for accelerated expansion and enhanced service delivery. This capital infusion is expected to fuel further development of their data analytics capabilities and broaden their market reach within the precision medicine landscape. The company is likely to focus on strengthening its strategic consulting partnerships and leveraging its market intelligence to drive innovation for its clients, solidifying its role as a key player in the evolving precision medicine sector.
See full DeciBio company page
